ARCHIVES

“Treatment INDs” Seen As Major Threat To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 34 | August 21, 1987

Download PDF Visit The Full Archive

Related Articles

NIH reauthorization Bill slates For House Vote;

May 28, 1993

In Brief: Columbia’s Marks Said To Be Cancer Panel New Member; Eight VCP Cregs Awarded

April 2, 1976

Congress Provides 7% Increase For NIH, 6.6% for NCI, In FY98 Appropriation

November 14, 1997

DRCCA Board Okays Chemoprevention RFA, Referral Guidelines

January 29, 1982

Upton Says He’s Still Undecided About Leaving NCI

September 28, 1979

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001